1. Home
  2. ACLS vs IDYA Comparison

ACLS vs IDYA Comparison

Compare ACLS & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axcelis Technologies Inc.

ACLS

Axcelis Technologies Inc.

HOLD

Current Price

$86.34

Market Cap

2.5B

Sector

Technology

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$32.15

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACLS
IDYA
Founded
1995
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.9B
IPO Year
2000
2019

Fundamental Metrics

Financial Performance
Metric
ACLS
IDYA
Price
$86.34
$32.15
Analyst Decision
Buy
Strong Buy
Analyst Count
4
16
Target Price
$101.50
$51.21
AVG Volume (30 Days)
634.7K
724.7K
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.90
EPS
3.80
N/A
Revenue
$839,048,000.00
$218,710,000.00
Revenue This Year
$1.93
N/A
Revenue Next Year
$7.91
$191.08
P/E Ratio
$22.23
N/A
Revenue Growth
N/A
3024.43
52 Week Low
$40.40
$13.45
52 Week High
$102.93
$39.28

Technical Indicators

Market Signals
Indicator
ACLS
IDYA
Relative Strength Index (RSI) 51.84 45.04
Support Level $78.24 $29.15
Resistance Level $91.51 $33.64
Average True Range (ATR) 3.27 1.34
MACD 0.33 -0.13
Stochastic Oscillator 74.46 41.56

Price Performance

Historical Comparison
ACLS
IDYA

About ACLS Axcelis Technologies Inc.

Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: